您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2014, Vol. 52 ›› Issue (9): 1-5.doi: 10.6040/j.issn.1671-7554.0.2014.271

• 基础医学 •    下一篇

干扰CD147表达抑制白血病细胞SHI-1增殖及移行

涂燕1,2, 李振江1, 汤爱平1, 费妍1, 李慧慧1, 李剑1, 贺文凤1   

  1. 1. 南昌大学第二附属医院血液科 江西省血液重点实验室, 江西 南昌 330006;
    2. 浙江大学金华医院血液科, 浙江 金华 321000
  • 收稿日期:2014-04-14 修回日期:2014-09-05 出版日期:2014-09-10 发布日期:2014-09-10
  • 基金资助:
    国家青年自然科学基金(30800490)；江西省科技厅基金

RNAi-mediated silencing of CD147 inhibits the proliferation and invasion of leukemic cells SHI-1

TU Yan1,2, LI Zhenjiang1, TANG Aiping1, FEI Yan1, LI Huihui1, LI Jian1, HE Wenfeng1   

  1. 1. Department of Hematology, Second Hospital Affiliated to Nanchang University, Key Laboratory of Hematology in Jiangxi Province, Nanchang 330006, Jiangxi, China;
    2. Department of Hematology, Jinhua Hospital of Zhejiang University, Jinhua 321000, Zhejiang, China
  • Received:2014-04-14 Revised:2014-09-05 Online:2014-09-10 Published:2014-09-10
  • Contact: 李振江。E-mail:lzjdgh@163.com E-mail:lzjdgh@163.com

PDF (PC)

241

摘要： 目的 构建针对细胞外基质金属蛋白酶诱导因子（CD147）的慢病毒干扰载体，探讨干扰CD147表达后对白血病细胞系SHI-1细胞体外增殖、侵袭、转移能力的影响。方法 设计针对CD147的干扰序列片段，构建于慢病毒载体pGCSIL-GFP上，重组慢病毒载体与包装载体共转染293T细胞，收集病毒上清，测定病毒滴度。病毒上清感染SHI-1细胞，RT-PCR法检测CD147、MMP-2及MMP-9 mRNA表达，Western blotting法检测CD147蛋白水平；MTT法检测细胞体外增殖能力，体外SHI-1细胞与骨髓基质细胞共培养跨Matrigel基质胶检测SHI-1细胞的体外侵袭能力。结果 成功构建慢病毒干扰载体，获得重组慢病毒，滴度达1×109 TU/mL。病毒感染SHI-1细胞后，SHI-1/CD147i细胞的CD147 mRNA较感染阴性对照病毒的SHI-1/NC细胞下调86.7%，CD147蛋白表达下降91%，SHI-1/CD147i细胞MMP-2及MMP-9 mRNA表达较SHI-1/NC细胞分别下降78.3%和70.6%。SHI-1/CD147i细胞体外增殖能力较SHI-1/NC及SHI-1细胞明显下降；与骨髓基质细胞共培养24h后，SHI-1、SHI-1/NC、SHI-1/CD147i细胞移行至Transwell下层的细胞占接种细胞数比例分别为（18.2±2.5）%、（16.5±2.7）%、（4.5±1.2）%，SHI-1/CD147细胞移行能力显著低于SHI-1和SHI-1/NC细胞。结论 干扰SHI-1细胞的CD147表达后，通过下调MMPs表达抑制SHI-1细胞体内外增殖及移行能力，CD147可能成为治疗急性白血病的靶点。

关键词: 细胞增殖, 细胞外基质金属蛋白酶诱导因子, 急性单核细胞白血病细胞株, RNA干扰, 基质金属蛋白酶, 细胞移行

Abstract: Objective To construct lentivirus vector for RNA interference (RNAi) targeting extracellular matrix metalloproteinase inducer (CD147) and to investigate the role of CD147 gene on the proliferation and infiltration of a human monocytic leukemic cell line SHI-1. Methods The complementary shRNA targeting CD147 was synthesized, and connected with pGCSIL-GFP vector. The 293T cells were transfected with recombined viral vector, packing plasmid pHelper 1.0 and pHelper 2.0 using Lipfectamine 2000. Then the recombinant lentiviruses were collected and infected the SHI-1 cells. The expressions of CD147, MMP-2 and MMP-9 in SHI-1 cells were detected by real time PCR. The protein of CD147 was detected by Western blotting. The capability of proliferation and infiltration of SHI-1 cell were examined by MTT and trans-matrigel invasion assay co-cultured with leukemia BMSCs in vitro. Results The lentivirus containing the CD147 shRNA was constructed successfully. The titer of recombined virus was 1×109 TU/mL. The mRNA and protein of CD147 in SHI-1/CD147i cells decreased by 86.7% and 91% respectively after the SHI-1 cells were infected by the lentivirus containing the CD147 siRNA. The proliferation capability of SHI-1/CD147i cells significantly decreased compared with that of SHI-1 and SHI-1/NC cells. The mRNA expressions of MMP-2 and MMP-9 in SHI-1/CD147i cells were significantly lower than that in SHI-1/NC and SHI-1 cells. The SHI-1/CD147i cells demonstrated significantly lower invasion rate than SHI-1 cells and SHI-1/NC cells when co-cultured with BMSCs. Conclusion CD147 plays important roles in the leukemia cell proliferation and infiltration. CD147 should be a potential target for the treatment of acute leukemia.

Key words: matrix metalloproteinase, Extracellular matrix metalloproteinase inducer, RNA interference, Cell invasion, Acute monocytic leukemia cell line, Cell proliferation

中图分类号: 

  • R733.7
[1] Stenzinger A, Wittschieber D, von W M, et al. High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer[J]. Human pathology, 2012, 43 (9): 1471-1481.
[2] Zeng W, Su J, Wu L, et al. CD147 promotes melanoma progression through hypoxia-induced MMP2 activation[J]. Curr Mol Med, 2014, 14(1): 163-173.
[3] Li Z J, Chen Z X, Cen J N, et al. Direct contact with bone marrow stromal cells promote the invasions of SHI-1 leukemia cells[J]. Chin Med J, 2013, 126 (14): 2731-2735.
[4] Froehlich H, Fellmann M, Sueltmann H, et al. Large scale statistical inference of signaling pathways from RNAi and microarray data[J]. BMC Bioinformatics, 2007, 8: 386-400.
[5] Ma Y, Chan C Y, He M L. RNA interference and antiviral therapy[J]. World J Gastroenterol, 2007, 13(39): 5169-5179.
[6] Jazag A, Ijichi H, Kanai F, et al. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-β[J]. Oncogene, 2005, 24(4): 662-671.
[7] Imamura T, Kanai F, Kawakami T, et al. Proteomic analysis of t heTGF-beta signaling pathway in pancreatic carcinoma cells using stable RNA interference to silence Smad4 expression[J]. Biochem Biophys Res Commun, 2004, 318 (1): 289-296.
[8] 黄灵芝, 赵敬湘, 刘淑静, 等. CD147 对白血病细胞U937生长和肿瘤形成的影响[J]. 生物技术通讯. 2008, 19(2): 203-206. HUANG Lingzhi, ZHAO Jingxiang, LIU Shujing, et al. The effect of CD147 on growth and tumorigenicity of leukemic U937 cells[J]. Letters in Biotechnology. 2008, 19(2): 203-206.
[9] Nabeshima K, Suzumiya J, Nagano M, et al. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas[J]. J Pathol, 2004, 202(3): 341-351.
[10] Fu J F, Fu J F, Chen X Q, et al. CD147 and VEGF co-expression predicts prognosis in patients with acute myeloid leukemia[J]. Jpn J Clin Oncol, 2010, 40(11): 1046-1052.
[11] Beesley A H, Cummings A J, Freitas, et al. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure[J]. Br J Haematol, 2005, 131(4): 447-456.
[12] Thorn C S, Noack F, Feller A C, et al. Application of newly developed tissue-arrays to study EMMPRIN (CD147) expression in malignant Non-Hodgkin lymphoma[J]. Cancer Genomics Proteomics, 2004, 1(1): 45-52.
[13] Arendt B K, Walters D K, Wu X, et al. Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: role in regulation of myeloma cell proliferation[J]. Leukemia, 2012, 26(10): 2286-2296.
[14] Xu J, Shen Z Y, Chen X G, et al. A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation[J]. Hepatology, 2007, 45(2): 269-276.
[1] 张宝文,雷香丽,李瑾娜,罗湘俊,邹容. miR-21-5p靶向调控TIMP3抑制2型糖尿病肾病小鼠肾脏系膜细胞增殖及细胞外基质堆积[J]. 山东大学学报 (医学版), 2020, 1(7): 7-14.
[2] 马青源,蒲沛东,韩飞,王超,朱洲均,王维山,史晨辉. miR-27b-3p调控SMAD1对骨肉瘤细胞增殖、迁移和侵袭作用的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 32-37.
[3] 宋昱,毛洋,刘庆梅,乔磊,帖媛媛,鲁璐,张蕾. 通心络对兔腹主动脉粥样硬化易损斑块中三维应变的影响[J]. 山东大学学报（医学版）, 2017, 55(5): 1-7.
[4] 李睿,马伟红,任满意,赵萌萌,姜珊,巨媛媛,郭颖,孙昭辉,隋树建. TWEAK与原发性高血压患者心脏重塑的相关性[J]. 山东大学学报（医学版）, 2017, 55(5): 49-55.
[5] 樊彦伟,严冬雪,招友. 富氢水对兔腰椎间盘退变的影响[J]. 山东大学学报（医学版）, 2017, 55(3): 38-42.
[6] 史培堃,曾贝妮,吴伟芳,胡晓燕,马天加,周亚滨. Keap1在肾细胞癌中的表达及其作用[J]. 山东大学学报（医学版）, 2017, 55(3): 94-99.
[7] 王伟,曹煜姗,孙达权,黄小琼,徐国强. 人TIMP-2蛋白在肝癌细胞迁移与侵袭中的作用[J]. 山东大学学报（医学版）, 2016, 54(7): 11-17.
[8] 巨媛媛,任满意,李睿,赵萌萌,隋树建. TWEAK通过ERK1/2通路促进大鼠心肌成纤维细胞MMP2与Ⅰ型胶原表达[J]. 山东大学学报（医学版）, 2016, 54(5): 23-28.
[9] 徐延杰,崔谊,李红霞,史文琦,李福艳,王建震,曾庆师. X线照射对U87胶质瘤多细胞球体MMP-2活性及Cho/Cr的影响[J]. 山东大学学报（医学版）, 2016, 54(4): 6-10.
[10] 吕树卿, 尉蔚, 张灿灿, 田永杰. HGF/PARP-1信号通路调控卵巢癌细胞侵袭转移的作用[J]. 山东大学学报（医学版）, 2015, 53(7): 1-7.
[11] 于磊, 李振. 白细胞介素33在脑血管病患者血清中的表达及其作用机制[J]. 山东大学学报（医学版）, 2015, 53(4): 75-79.
[12] 高峰, 康白, 杨洪鸣, 赵廷坤, 曲梅花, 王金红. 皮肤T细胞淋巴瘤相关抗原5在肿瘤细胞株中的表达[J]. 山东大学学报（医学版）, 2015, 53(3): 41-45.
[13] 刘振中, 姜笃银, 王魏, 宗宪磊, 张基勋, 刘磊. 转化生长因子-β1噬菌体模拟肽促进成纤维细胞增殖的效果[J]. 山东大学学报（医学版）, 2015, 53(3): 50-55.
[14] 张伶俐, 周莹, 李小荷, 李慧, 钟明, 张薇. 中国房颤人群心肌组织中MMPs与TIMPs的mRNA表达水平的Meta分析[J]. 山东大学学报（医学版）, 2015, 53(1): 47-53.
[15] 黄静, 胥莹, 刘毅, 辛玮, 赵胥, 刘蕾, 完强. 乙酰辅酶A羧化酶2表达下调对高糖培养的人肾小管上皮细胞脂质沉积和间充质转化的影响[J]. 山东大学学报（医学版）, 2014, 52(7): 16-21.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发